395828009: Pioglitazone (substance)

SNOMED CT Concept\Substance\...

\Substance categorized by disposition\Receptor agonist\...

\Peroxisome proliferator-activated receptor agonist\Thiazolidinedione (substance)\Pioglitazone (substance)

\Peroxisome proliferator-activated gamma receptor agonist\Thiazolidinedione (substance)\Pioglitazone (substance)

\A grouper concept for substances that are used in medicinal products for medical treatment, and also psychoactive substances that have few or no legitimate medical uses or that are not legally available to the person using them.\Peroxisome proliferator-activated receptor agonist\Thiazolidinedione (substance)\Pioglitazone (substance)

\Substance categorised by structure\Chemical\Chemical categorized by structure (substance)\...

\Sulfur and/or sulfur compound\Sulfur compound\Organic sulfur compound\Thiazole (substance)\Thiazolidinedione (substance)\Pioglitazone (substance)

\Organic compound\Organic sulfur compound\Thiazole (substance)\Thiazolidinedione (substance)\Pioglitazone (substance)

Status: current, Not sufficiently defined by necessary conditions definition status (core metadata concept). Date: 31-Jan 2003. Module: SNOMED CT core

Descriptions:

Expanded Value Set

Outbound Relationships	Type	Target	Active	Characteristic	Refinability	Group	Values
Pioglitazone (substance)	Is a	agent antidiabétique	false	Inferred relationship	Some
Pioglitazone (substance)	Is a	Thiazolidinedione (substance)	true	Inferred relationship	Some
Pioglitazone (substance)	This attribute specifies the behavior that a substance will exhibit or participate in, given the appropriate context.	Peroxisome proliferator-activated gamma receptor agonist (disposition)	true	Inferred relationship	Some

Inbound Relationships	Type	Active	Source	Characteristic	Refinability	Group
Product containing pioglitazone (medicinal product)	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	True	Pioglitazone (substance)	Inferred relationship	Some	1
Pioglitazone (as pioglitazone hydrochloride) 30 mg oral tablet	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Pioglitazone (substance)	Inferred relationship	Some
Product containing precisely pioglitazone (as pioglitazone hydrochloride) 15 milligram/1 each conventional release oral tablet (clinical drug)	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Pioglitazone (substance)	Inferred relationship	Some
Product containing precisely pioglitazone (as pioglitazone hydrochloride) 45 milligram/1 each conventional release oral tablet (clinical drug)	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Pioglitazone (substance)	Inferred relationship	Some
Pioglitazone hydrochloride	Is a	False	Pioglitazone (substance)	Inferred relationship	Some
Product containing metformin and pioglitazone (medicinal product)	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	True	Pioglitazone (substance)	Inferred relationship	Some	2
Product containing precisely metformin hydrochloride 500 milligram and pioglitazone hydrochloride 15 milligram/1 each conventional release oral tablet	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Pioglitazone (substance)	Inferred relationship	Some
Product containing precisely metformin hydrochloride 850 milligram and pioglitazone (as pioglitazone hydrochloride) 15 milligram/1 each conventional release oral tablet (clinical drug)	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Pioglitazone (substance)	Inferred relationship	Some
Product containing glimepiride and pioglitazone (medicinal product)	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	True	Pioglitazone (substance)	Inferred relationship	Some	2
Product containing precisely glimepiride 2 milligram and pioglitazone hydrochloride 30 milligram/1 each conventional release oral tablet	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Pioglitazone (substance)	Inferred relationship	Some
Product containing precisely glimepiride 4 milligram and pioglitazone hydrochloride 30 milligram/1 each conventional release oral tablet	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Pioglitazone (substance)	Inferred relationship	Some
Pioglitazone 30mg + metformin 1g m/r tablet	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Pioglitazone (substance)	Inferred relationship	Some
Pioglitazone 15mg + metformin 1g m/r tablet	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Pioglitazone (substance)	Inferred relationship	Some
Pioglitazone (as pioglitazone hydrochloride) 30 mg oral tablet	This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon.	True	Pioglitazone (substance)	Inferred relationship	Some	1
Product containing precisely pioglitazone (as pioglitazone hydrochloride) 15 milligram/1 each conventional release oral tablet (clinical drug)	This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon.	True	Pioglitazone (substance)	Inferred relationship	Some	1
Product containing precisely pioglitazone (as pioglitazone hydrochloride) 45 milligram/1 each conventional release oral tablet (clinical drug)	This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon.	True	Pioglitazone (substance)	Inferred relationship	Some	1
Product containing precisely metformin hydrochloride 850 milligram and pioglitazone (as pioglitazone hydrochloride) 15 milligram/1 each conventional release oral tablet (clinical drug)	This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon.	False	Pioglitazone (substance)	Inferred relationship	Some	1
Product containing precisely metformin hydrochloride 850 milligram and pioglitazone (as pioglitazone hydrochloride) 15 milligram/1 each conventional release oral tablet (clinical drug)	This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon.	True	Pioglitazone (substance)	Inferred relationship	Some	2
Pioglitazone 30mg + metformin 1g prolonged-release oral tablet	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Pioglitazone (substance)	Inferred relationship	Some
Pioglitazone 15mg + metformin 1g prolonged-release oral tablet	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Pioglitazone (substance)	Inferred relationship	Some
Product containing pioglitazone in oral dose form (medicinal product form)	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	True	Pioglitazone (substance)	Inferred relationship	Some	1
Metformin- and pioglitazone-containing product in oral dose form	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	True	Pioglitazone (substance)	Inferred relationship	Some	2
Product containing glimepiride and pioglitazone in oral dose form (medicinal product form)	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	True	Pioglitazone (substance)	Inferred relationship	Some	2
Pioglitazone hydrochloride	This attribute indicates that the concept is a structural modification of another concept, and that the substance's intrinsic physicochemical properties remain unchanged.	True	Pioglitazone (substance)	Inferred relationship	Some
Glimepiride and pioglitazone only product	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	True	Pioglitazone (substance)	Inferred relationship	Some	2
Product containing only metformin and pioglitazone (medicinal product)	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	True	Pioglitazone (substance)	Inferred relationship	Some	2
Product containing only pioglitazone (medicinal product)	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	True	Pioglitazone (substance)	Inferred relationship	Some	1
Glimepiride and pioglitazone only product in oral dose form	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	True	Pioglitazone (substance)	Inferred relationship	Some	2
Product containing only pioglitazone in oral dose form (medicinal product form)	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	True	Pioglitazone (substance)	Inferred relationship	Some	1
Metformin and pioglitazone only product in oral dose form	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	True	Pioglitazone (substance)	Inferred relationship	Some	2
Product containing precisely glimepiride 2 milligram and pioglitazone (as pioglitazone hydrochloride) 30 milligram/1 each conventional release oral tablet (clinical drug)	This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon.	True	Pioglitazone (substance)	Inferred relationship	Some	2
Product containing precisely glimepiride 4 milligram and pioglitazone (as pioglitazone hydrochloride) 30 milligram/1 each conventional release oral tablet (clinical drug)	This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon.	True	Pioglitazone (substance)	Inferred relationship	Some	2
Metformin hydrochloride 500 mg and pioglitazone (as pioglitazone hydrochloride) 15 mg oral tablet	This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon.	True	Pioglitazone (substance)	Inferred relationship	Some	2
Product containing alogliptin and pioglitazone (medicinal product)	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	True	Pioglitazone (substance)	Inferred relationship	Some	1
Product containing only alogliptin and pioglitazone (medicinal product)	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	True	Pioglitazone (substance)	Inferred relationship	Some	1
Product containing alogliptin and pioglitazone in oral dose form (medicinal product form)	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	True	Pioglitazone (substance)	Inferred relationship	Some	1
Alogliptin and pioglitazone only product in oral dose form	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	True	Pioglitazone (substance)	Inferred relationship	Some	1
Product containing precisely alogliptin (as alogliptin benzoate) 25 milligram and pioglitazone (as pioglitazone hydrochloride) 45 milligram/1 each conventional release oral tablet (clinical drug)	This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon.	True	Pioglitazone (substance)	Inferred relationship	Some	1
Product containing precisely alogliptin (as alogliptin benzoate) 25 milligram and pioglitazone (as pioglitazone hydrochloride) 15 milligram/1 each conventional release oral tablet (clinical drug)	This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon.	True	Pioglitazone (substance)	Inferred relationship	Some	1
Product containing precisely alogliptin (as alogliptin benzoate) 25 milligram and pioglitazone (as pioglitazone hydrochloride) 30 milligram/1 each conventional release oral tablet (clinical drug)	This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon.	True	Pioglitazone (substance)	Inferred relationship	Some	1
Alogliptin (as alogliptin benzoate) 12.5 mg and pioglitazone (as pioglitazone hydrochloride) 30 mg oral tablet	This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon.	True	Pioglitazone (substance)	Inferred relationship	Some	1
Product containing precisely alogliptin (as alogliptin benzoate) 12.5 milligram and pioglitazone (as pioglitazone hydrochloride) 15 milligram/1 each conventional release oral tablet (clinical drug)	This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon.	True	Pioglitazone (substance)	Inferred relationship	Some	1
Product containing precisely alogliptin (as alogliptin benzoate) 12.5 milligram and pioglitazone (as pioglitazone hydrochloride) 45 milligram/1 each conventional release oral tablet (clinical drug)	This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon.	True	Pioglitazone (substance)	Inferred relationship	Some	1

This concept is not in any reference sets

Back to Start

Id	Description	Lang	Type	Status	Case?	Module
1469768013	Pioglitazone (substance)	en	Fully specified name	Active	Entire term case insensitive (core metadata concept)	SNOMED CT core
1489469013	Pioglitazone	en	Synonym (core metadata concept)	Active	Entire term case insensitive (core metadata concept)	SNOMED CT core
49941000195117	pioglitazone	it	Synonym (core metadata concept)	Active	Entire term case insensitive (core metadata concept)	SNOMED CT Switzerland NRC maintained Module
189791000077113	pioglitazone	fr	Synonym (core metadata concept)	Active	Entire term case insensitive (core metadata concept)	SNOMED CT Switzerland NRC maintained Module
64121000195117	Pioglitazon	de	Synonym (core metadata concept)	Active	Entire term case sensitive (core metadata concept)	SNOMED CT Switzerland NRC maintained Module